Core Viewpoint - The resignation of Chen Dongfeng, the General Manager of Lianchi Hospital Group, raises concerns about the company's future strategic planning and development amidst ongoing challenges in its listing process [7]. Group 1: Resignation of Key Executive - Chen Dongfeng has resigned from his positions as a director, member of the remuneration and assessment committee, and General Manager of Lianchi Hospital, effective immediately due to personal reasons [2]. - Chen Dongfeng's annual salary was 1.07 million yuan, significantly higher than that of the Chairman and other executives [2]. Group 2: Company Performance - Lianchi Hospital's revenue has shown steady growth, increasing from 228 million yuan in 2018 to 419 million yuan in 2024, with a 19.95% year-on-year growth in the first half of 2025, achieving 233 million yuan [4]. Group 3: Listing Attempts - The company has faced multiple setbacks in its listing journey, initially attempting to list on the New Third Board in 2015, then shifting to the Growth Enterprise Market in 2021, and later to the Beijing Stock Exchange in 2022 [5]. - As of July 2024, Lianchi Hospital announced plans to apply for listing on the Beijing Stock Exchange, intending to raise funds for the relocation of the Zibo Lianchi Orthopedic Hospital and for information technology upgrades [5]. - However, the company has not yet engaged a counseling agency or signed a counseling agreement, indicating significant uncertainty in its listing process [5][6].